Cargando…
A liver fibrosis cocktail? Psoriasis, methotrexate and genetic hemochromatosis
BACKGROUND: Pathologists are often faced with the dilemma of whether to recommend continuation of methotrexate therapy for psoriasis within the context of an existing pro-fibrogenic risk factor, in this instance, patients with genetic hemochromatosis. CASE PRESENTATIONS: We describe our experience w...
| Autores principales: | , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2005
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1318467/ https://www.ncbi.nlm.nih.gov/pubmed/16316460 http://dx.doi.org/10.1186/1471-5945-5-12 |